Chemical compound, pharmaceutical composition, methods for synthesizing a chemical compound, for treating ischemia-reperfusion damage, liver disease, arrhythmia and cancerous and precancerous cell (s), to increase expression of connexin 43 is a disease with a chemical composition comprising a carotenoid derivative and for reducing a c-reactive protein.

摘要

"CHEMICAL COMPOUND, PHARMACEUTICAL COMPOSITION, METHODS TO SYNTHESIZE CHEMICAL COMPOUND, TO TREAT ISCHEMIA-REPERFUSION DAMAGE, ARRYTHMIA AND SUGAR CANCER (S) CANCER (S) CELLS 43 AND A DISEASE WITH A CHEMICAL COMPOSITION UNDERSTANDING A CAROTENOID DERIVATIVE AND TO REDUCE A C-REACTIVE PROTEIN ". Method for inhibiting and / or improving the occurrence of diseases associated with reactive oxygen species reactive, radical and / or non-radical nitrogen species in an individual, thus an individual is administered with a carotenoid structural analog, either alone or in combination with another carotenoid analog, or co-antioxidant formulation. The analog or combination of analogs is administered such that the individual's risk of experiencing diseases associated with reactive oxygen species, reactive nitrogen species, radicals and / or non-radicals can thus be reduced. The analog or combination of analogs may be administered to an individual for the inhibition and / or amelioration of ischemia-reperfusion damage. The analog or combination of analogs may be administered to an individual for inhibiting and / or ameliorating liver disease. The analog or combination of analogs may be administered to an individual for inhibition and / or amelioration of cancer. The analog or combination of analogs may be administered to an individual for inhibiting and / or ameliorating cardiac arrhythmia and / or sudden cardiac death. The analog or combination of analogs may be administered to an individual for the inhibition and / or amelioration of any disease involving the production of reactive oxygen species, reactive nitrogen species, radicals and / or non-radicals. In one embodiment, a water-soluble and / or water-dispersible astaxanthin analog is particularly effective. This invention further includes pharmaceutical compositions comprising structural carotenoid analogs either alone or in combination.